C. Melman

A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities.

J. Buitelaar, P. Cohen-Kettenis, R. J. van der Gaag, 2001, The Journal of clinical psychiatry.

Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718.

A. IJzerman, A. van der Bent, W Soudijn, 1992, Journal of medicinal chemistry.

Chemical modification of cholecystokinin-A receptors in rat pancreatic membranes.

A. IJzerman, C. Melman, 1992, European Journal of Biochemistry.

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study

Husseini Manji, Frank Wiegand, Wayne C. Drevets, 2016, Biological Psychiatry.

Risperidone in the treatment of aggressive behaviour disorders in adolescents with mild mental retardation. A prospective, randomised, double-blind, placebo-controlled trial

J. Buitelaar, R. J. Gaag, C. Melman, 1998, European Neuropsychopharmacology.

Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study

P. Dries, J. E. Hovens, A. Loonen, 2005, Journal of psychopharmacology.

Efficacy and Safety of Intravenous Esketamine in Patients with Treatment-resistant Depression: A Double-blind, Double-randomization, Placebo-controlled Phase 2a Study

W. Drevets, P. Sienaert, H. Manji, 2013 .